Although lymphopenia is currently considered a good predictor for the prognosis of COVID-19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment.
Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease
Barnabei R.;Di Michele G.;Amicosante G.;Perilli M.;Bellio P.;Piccirilli A.;Celenza G.
2021-01-01
Abstract
Although lymphopenia is currently considered a good predictor for the prognosis of COVID-19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Clinical Case Reports - 2021 - Barnabei.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
243.13 kB
Formato
Adobe PDF
|
243.13 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
